Apetamin Hepatotoxicity: Potential Consequences of Purchasing a Body Enhancement Drug Off the Internet. Issue 6 (23rd June 2020)
- Record Type:
- Journal Article
- Title:
- Apetamin Hepatotoxicity: Potential Consequences of Purchasing a Body Enhancement Drug Off the Internet. Issue 6 (23rd June 2020)
- Main Title:
- Apetamin Hepatotoxicity: Potential Consequences of Purchasing a Body Enhancement Drug Off the Internet
- Authors:
- Garland, Victoria
Kumar, Anita
Theisen, Brian
Borum, Marie L. - Abstract:
- ABSTRACT: We report Apetamin (cyproheptadine lysine and vitamin syrup), a non-US Food and Drug Administration-approved weight gain supplement, causing drug-induced autoimmune hepatitis. A 40-year-old previously healthy woman presented with fatigue, right-sided abdominal discomfort, and jaundice 6 weeks after starting Apetamin, which she learned from social media for figure augmentation. Labs were significant for elevated transaminases, positive smooth muscle antibody, and increased immunoglobulins. Biopsy indicated drug-induced autoimmune hepatitis. Symptoms improved with prednisone, azathioprine, and stopping Apetamin which contains cyproheptadine, a known hepatotoxin. The case reveals the influence of social media and its impact on health and the importance of a complete drug history.
- Is Part Of:
- ACG Case Reports Journal. Volume 7:Issue 6(2020)
- Journal:
- ACG Case Reports Journal
- Issue:
- Volume 7:Issue 6(2020)
- Issue Display:
- Volume 7, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 7
- Issue:
- 6
- Issue Sort Value:
- 2020-0007-0006-0000
- Page Start:
- e00398
- Page End:
- Publication Date:
- 2020-06-23
- Journal URLs:
- http://journals.lww.com/pages/default.aspx ↗
- DOI:
- 10.14309/crj.0000000000000398 ↗
- Languages:
- English
- ISSNs:
- 2326-3253
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24315.xml